| Influenza Vaccines Market Research Reports, Growth and Analysis by Top Leaders Forecast 2023 - 2031
The influenza vaccines market in the United States was valued at US$ 3,962 million in 2022 and is expected to reach US$ 8,347 million by 2031, registering a CAGR of 8.6% during the forecast period.
DELHI, India - June 14, 2023 - PRLog -- This Well-Versed and Comprehensive United States Influenza Vaccines Market Research Report 2023 is Divided into 20 Chapters: - Chapter 1 contains a brief description of the market under study
- Chapter 2 describes the research methodology of the study
- Chapter 3 identifies key trends and prospects for the U.S. influenza vaccine market and draws key conclusions
- Chapter 4 discusses the market scenario for influenza vaccines in the United States in terms of historical market values and projections through 2031
- Chapter 5 analysis of adults and children in the United States vaccinated with influenza vaccines and projection through 2031
- Chapter 6 highlights key market dynamics in the U.S. influenza vaccine market, including factors driving the market, prevailing barriers, potential opportunities, and future trends. This section also includes an analysis of the impact of the driving and restraining factors
- Chapter 7 offers comprehensive insights into the latest pricing trends and analysis of the U.S. influenza vaccine market
- Chapter 8 includes a comprehensive analysis of influenza vaccine production, supply, and distribution in the United States (by company)
- Chapter 9 provides a complete overview of influenza vaccine distribution and demand in the United States
- Chapter 10 investigates the effectiveness of influenza vaccines in the United States
- Chapter 11 thorough evaluation of rapid diagnostic tests for influenza management
- Chapter 12 carefully evaluates the distribution channel and technique of influenza vaccination in the United States
- Chapter 13 characteristics of reimbursement structures in the influenza vaccine market in the united states
- Chapter 14 detailed insights into the legal framework of the U.S. influenza vaccine market
- Chapter 15 tracks competitive developments, approaches, recent industry developments, and mergers and acquisitions, collaboration, distribution, exclusivity, and licensing agreements.
- Chapter 16 an informative study was conducted on promising influenza vaccines in clinical development.
- Chapter 17 analyses recent clinical trials of the influenza vaccine
- Chapter 18 and 19 provides the industry landscape and detailed profiles of key and promising companies operating in the influenza vaccine market in the United States. The companies have been profiled based on their key facts, business description, products and services, current vaccine portfolio, promising vaccines in clinical development, platform technology, and key developments.
- Chapter 20, i.e. the appendix contains a brief overview of the company, a glossary, contact information, and the disclaimer section.
More Details @ https://dpiresearch.com/united-states-influenza-vaccines-...
| |
Account Phone Number